Literature DB >> 16622741

Tumor angiogenesis and antiangiogenic therapy: current status and perspective.

Shigeki Arii1.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16622741     DOI： 10.1007/s10147-006-0569-2

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN： 1341-9625            Impact factor:   3.402


× No keyword cloud information.
  5 in total

1.  Induction of angiopoietin-2 gene expression by COX-2: a novel role for COX-2 inhibitors during hepatocarcinogenesis.

Authors:  Shinji Tanaka; Jack R Wands; Shigeki Arii
Journal:  J Hepatol       Date:  2005-11-02       Impact factor: 25.083

Review 2.  Tumor angiogenesis: therapeutic implications.

Authors:  J Folkman
Journal:  N Engl J Med       Date:  1971-11-18       Impact factor: 91.245

3.  Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells.

Authors:  N Ferrara; W J Henzel
Journal:  Biochem Biophys Res Commun       Date:  1989-06-15       Impact factor: 3.575

4.  Endostatin: an endogenous inhibitor of angiogenesis and tumor growth.

Authors:  M S O'Reilly; T Boehm; Y Shing; N Fukai; G Vasios; W S Lane; E Flynn; J R Birkhead; B R Olsen; J Folkman
Journal:  Cell       Date:  1997-01-24       Impact factor: 41.582

Review 5.  Targeting HIF-1 for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.